Honap S[au] - Search Results

Year	Number of Results
1989	1
2010	1
2019	3
2020	5
2021	9
2022	8
2023	4

1

Effectiveness and Safety of Ustekinumab in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis.

Honap S, Meade S, Ibraheim H, Irving PM, Jones MP, Samaan MA. Honap S, et al. Dig Dis Sci. 2022 Mar;67(3):1018-1035. doi: 10.1007/s10620-021-06932-4. Epub 2021 Mar 16. Dig Dis Sci. 2022. PMID: 33723700

2

Fat and Hidden Liver Cancer.

Honap S, Oben JA. Honap S, et al. Clin Liver Dis (Hoboken). 2021 Feb 28;17(2):49-52. doi: 10.1002/cld.1011. eCollection 2021 Feb. Clin Liver Dis (Hoboken). 2021. PMID: 33680434 Free PMC article. Review. No abstract available.

3

5-ASAs in Crohn's Disease: Time to Stop the Salicylate?

Honap S, Sharma E, Samaan MA. Honap S, et al. Dig Dis Sci. 2022 Jul;67(7):2699-2700. doi: 10.1007/s10620-021-07304-8. Epub 2021 Nov 19. Dig Dis Sci. 2022. PMID: 34797441 No abstract available.

4

Editorial: is tofacitinib another rescue option for acute severe ulcerative colitis?

Honap S, Pavlidis P, Irving PM. Honap S, et al. Aliment Pharmacol Ther. 2021 Aug;54(3):341-342. doi: 10.1111/apt.16482. Aliment Pharmacol Ther. 2021. PMID: 34236096 No abstract available.

5

Response to 'Clinical Efficacy of Tofacitinib in Moderate to Severe Ulcerative Colitis'.

Honap S, Irving PM, Kennedy NA. Honap S, et al. J Crohns Colitis. 2021 Oct 7;15(10):1775-1776. doi: 10.1093/ecco-jcc/jjab080. J Crohns Colitis. 2021. PMID: 34125175 No abstract available.

6

Editorial: protecting hypoxia-inducible factor-1α and gut integrity with GB004-a promising therapeutic approach for ulcerative colitis?

Honap S, Dart RJ, Samaan MA. Honap S, et al. Aliment Pharmacol Ther. 2022 Mar;55(6):733-734. doi: 10.1111/apt.16761. Aliment Pharmacol Ther. 2022. PMID: 35245958 No abstract available.

7

Positioning biologics and new therapies in the management of inflammatory bowel disease.

Honap S, Cunningham G, Tamilarasan AG, Irving PM. Honap S, et al. Curr Opin Gastroenterol. 2019 Jul;35(4):296-301. doi: 10.1097/MOG.0000000000000546. Curr Opin Gastroenterol. 2019. PMID: 31021925 Review.

8

Anogenital Crohn's Disease and Granulomatosis: A Systematic Review of Epidemiology, Clinical Manifestations, and Treatment.

Honap S, Meade S, Spencer A, Pavlidis P, Luber RP, Calonje E, Rashidghamat E, Bunker CB, Lewis F, Irving PM. Honap S, et al. J Crohns Colitis. 2022 Jun 24;16(5):822-834. doi: 10.1093/ecco-jcc/jjab211. J Crohns Colitis. 2022. PMID: 34962991

9

Can We Predict the Toxicity and Response to Thiopurines in Inflammatory Bowel Diseases?

Luber RP, Honap S, Cunningham G, Irving PM. Luber RP, et al. Among authors: honap s. Front Med (Lausanne). 2019 Nov 28;6:279. doi: 10.3389/fmed.2019.00279. eCollection 2019. Front Med (Lausanne). 2019. PMID: 31850357 Free PMC article. Review.

10

Vedolizumab-Associated Drug-Induced Liver Injury: A Case Series.

Honap S, Sticova E, Theocharidou E, Berry P, Irving PM, Samaan MA, Kotha S. Honap S, et al. Inflamm Bowel Dis. 2021 Feb 16;27(3):e32-e34. doi: 10.1093/ibd/izaa286. Inflamm Bowel Dis. 2021. PMID: 33155638 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

26 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

26 results

Results by year